Making a REAL difference in people’s lives

The Otsuka Patient Assistance Foundation, Inc. (OPAF) is a 501c(3) nonprofit organization that provides eligible uninsured or underinsured patients with prescribed Otsuka medication free of cost.

The OPAF mission is to improve the health & wellness for eligible patients by reducing barriers to healthy living and enabling patients along their health journeys.

U.S.Based Healthcare Professionals (HCPS)

You can complete applications on behalf of patients with access barriers or those who are uninsured or underinsured. Apply online through the OPAF Care Connect Portal.

Apply online

When you sign up for the OPAF Care Connect Portal, you can:

Submit OPAF applications online. You’ll receive eligibility determination within 48 hours of completing and submitting all supporting documentation.
Prescription order submission and tracking for:
- NUEDEXTA®(dextromethorphan HBr and quinidine sulfate) capsules
- ABILIFY MAINTENA®(aripiprazole) extended release injectable suspension
- JYNARQUE®(tolvaptan) tablets
- REXULTI®(brexpiprazole) tablets
- SAMSCA®(tolvaptan) tablets
Access prescription template for e-prescribing.
Submit prescriptions to our partner pharmacy: LabCorps Specialty Pharmacy

For states that require eScribe, please submit a prescription via your EMR system to LabCorp Specialty Pharmacy, 100 Technology Park, Suite 158, Lake Mary, Florida by Phone at (866) 842-2147 or by Fax at (866) 842-1509 during business hours: Monday-Friday, 8am to 8pm ET.

See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

When you sign up for the OPAF Care Connect Portal, you can

Submit OPAF applications online. You’ll receive eligibility determination within 48 hours of completing and submitting all supporting documentation.
Prescription order submission and tracking for:
- NUEDEXTA®(dextromethorphan HBr and quinidine sulfate)
- ABILIFY MAINTENA®(aripiprazole) extended release injectable suspension
- JYNARQUE®(tolvaptan) tablets
- REXULTI®(brexpiprazole) tablets
- SAMSCA®(tolvaptan) tablets
Access prescription template for e-prescribing.
Submit prescriptions to our partner pharmacy: LabCorps Specialty Pharmacy

For states that require eScribe, please submit a prescription via your EMR system to LabCorp Specialty Pharmacy, 100 Technology Park, Suite 158, Lake Mary, Florida by Phone at (866) 842-2147 or by Fax at (866) 842-1509 during business hours: Monday-Friday, 8am to 8pm ET.

See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

Patient application for NUEDEXTA®(dextromethorphan HBr and quinidine sulfate) capsules

Download

Patient application for ABILIFY MAINTENA® (aripiprazole) extended release injectable suspension

Download

Patient application for REXULTI® (brexpiprazole) tablets

Download

Patient application for SAMSCA® (tolvaptan) tablets

Download

Patient application for JYNARQUE® (tolvaptan) tablets

Download

Patients

We encourage you to apply and let a dedicated Patient Access Advocate do an in-depth eligibility analysis for you. You can contact a dedicated Patient Access Advocate at 1-855-727-6274 (Monday-Friday 8am to 8pm ET, excluding National Holidays) with questions.

CHECK ELIGIBILITY

OR

Frequently Asked Questions

If the Eligibility tool indicates that I may be eligible, can I submit an application?

Yes, you can begin the application process by applying via the OPAF Care Connect Patient Portal. The OPAF team will work with your healthcare professional [HCP] to finish the application process. When submitting your information into the portal, please be sure to upload all of the required documentation such as income verification, U.S. home address verification, and insurance denial information.

GET ANSWERS TO OTHER FAQ

Have questions about OPAF and don’t have time for a phone call?

Send a secure message directly to a dedicated OPAF Patient Access Advocate.

SEND A SECURE MESSAGE

Supported Medications

OPAF provides eligible patients no-cost support for the following prescribed medications:

See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.

Secure messaging ensures patient privacy because it is a HIPAA-compliant, password-protected electronic messaging platform. You can communicate directly with an OPAF Patient Access Advocate without having to pick up the phone. Through the platform you can securely send electronic messages with any questions, communications, and documents at your convenience.

Because it is HIPAA-compliant, there is a one-time account activation process. The activation process takes less than 3 minutes. Once your account is active, you can send messages to OPAF immediately.

To setup your OPAF secure message account follow the steps below:

Click on the (button or envelope) below to start the process
The system will prompt you to enter your email address as a "New to SecureContact"
A verification email will be sent to the email address that you entered
In your email inbox, you will find a message from "[email protected]"
Open this message and click on the link to activate your account
Complete the account activation by creating a password
Your account is active, and you can securely send a message to OPAF

If you have any questions, please contact OPAF at 1-855-727-6274 8:00 AM - 8:00 PM ET.

MESSAGE US

message